[Position of the Drug Committee of German Physicians on vaccination against the new influenza A (H1N1)].
D000276:Adjuvants, Immunologic / Q000009:adverse effects; D002648:Child; D004196:Disease Outbreaks / Q000517:prevention & control*; D005260:Female; D005858:Germany; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D007251:Influenza, Human / Q000276:immunology / Q000451:nursing* / Q000517:prevention & control; D032541:Mass Vaccination / Q000451:nursing*; D010606:Pharmacy and Therapeutics Committee; D011247:Pregnancy; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects; D011358:Product Surveillance, Postmarketing; D012307:Risk Factors; D013849:Thimerosal / Q000009:adverse effects
D000276:Adjuvants, Immunologic; D007252:Influenza Vaccines; D011310:Preservatives, Pharmaceutical; D013849:Thimerosal